SNCA and synucleinopathy: Additional evidences supporting a relationship between alpha-synuclein amyloid fibril diversity and the nature of pathology come from methods where pathogenic alpha-synuclein-rich aggregates from the central or peripheral nervous system of patients suffering from different synucleinopathies were used to seed the aggregation of monomeric alpha-synuclein in test tubes.